216.77
-0.90 (-0.41%)
JAGSNPHARM • 02 Dec, 2025 | 01:29 PM
1Y Annualised Return
▲42.26%
3Y Annualised Return
▲16.46%
5Y Annualised Return
▲74.65%
10Y Annualised Return
▲34.56%
Jagsonpal Pharmaceuticals Stock Performance
|
|
|
Jagsonpal Pharmaceuticals Company background
Founded in: 1978
Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multipurpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd.The company has a strategic alliance with Fidia Spa, Italy and B Spofola, Czechoslovakia to manufacture sophisticated drugs in India. It has tied up with another Israelbased company, Makhteshim Chemical Works, for acquiring the marketing rights of an antioxidant product. In 1994, the company has also promoted Aresco Financial Services, a new financial company.The Companys RD activities have resulted in manufacturing process upgradation, improving packaging, and cost containment. Its RD activities are geared towards development of new product technologies which can be commercialised in future.It has tied up with Lycored Natural Products Industries (LNP) of Israel, to launch a completely natural Lycopene bioactive product, Lycored, in India and SouthEast Asia.In the fiscal 2001, the companys sales grew by 15% to Rs 136.52 crore and the profit at the net level was up 8% to Rs 10.15 crore. This was achieved against heavy odds, such as, sluggish market trends, lower growth rate of the industry and severe competition from drug majors. However the company has introduced various measures to counter the above factors so as to achieve continued growth and opportunity.The new manufacturing facility at Pantnagar, Uttarakhand started production in April 2009. The Company launched two brands, Divatrone and ProRetro in the market segment, Dydrogesterone, which was earlier dominated by a global pharma Company in August, 2021.On June 27, 2022, Infinity Holdings, an Indiafocused investment group acquired control over the Company consequent to acquisition of 43.73% of equity capital and became Promoters of the Company. The Company identified several products as part of new launches such as Indocap Gel, Lycored Plus, MemUp, Queezy ER to enhance healthcare professionals confidence and improve patient outcomes in 202324. It acquired the India and Bhutan business of Yash Pharma in June, 2024.
Jagsonpal Pharmaceuticals Share Price Today
As of 2 Dec 2025, Jagsonpal Pharmaceuticals share price is ₹217.2. The stock opened at ₹217.7 and had closed at ₹217.7 the previous day. During today’s trading session, Jagsonpal Pharmaceuticals share price moved between ₹213.00 and ₹219.00, with an average price for the day of ₹216.00. Over the last 52 weeks, the stock has recorded a low of ₹192.85 and a high of ₹325.70. In terms of performance, Jagsonpal Pharmaceuticals share price has declined by 8.3% over the past six months and has increased by 42.26% over the last year.
Jagsonpal Pharmaceuticals SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹31,05,526 in 5 years with a gain of ₹28,05,526 (+935.18%)
Jagsonpal Pharmaceuticals Fundamental
Market Cap (in crs)
1,453.63
Face Value
2
Turnover (in lacs)
89.31
Key Metrics
Qtr Change %
33.30% Fall from 52W High
-9.4
Dividend yield 1yr %
Below industry Median
1.2
Jagsonpal Pharmaceuticals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
216.77
Current Price
Day EMA5
210.60
Day EMA10
208.80
Day EMA12
208.90
Day EMA20
210.50
Day EMA26
212.00
Day EMA50
218.10
Day EMA100
224.80
Day EMA200
224.20
Day SMA5
207.40
Day SMA10
206.40
Day SMA20
210.40
Day SMA30
213.50
Day SMA50
217.90
Day SMA100
234.60
Day SMA150
231.40
Day SMA200
228.50
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 35078 Rs | 54946 Rs |
Week Rs | 42591 Rs | 91636 Rs |
Month Rs | 40100 Rs | 75284 Rs |
Resistance & Support
216.89
Pivot
Resistance
First Resistance
220.18
Second Resistance
222.69
Third Resistance
225.98
Support
First Support
214.38
Second support
211.09
Third Support
208.58
Relative Strength Index
56.04
Money Flow Index
50.09
MACD
-3.07
MACD Signal
-4.37
Average True Range
7.22
Average Directional Index
26.25
Rate of Change (21)
-1.12
Rate of Change (125)
-8.18
Jagsonpal Pharmaceuticals Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,645.00 | 1,400.57 | 1242.95 | 2684.45 | 1,646.40 | -0.12% | 2.60% | -9.07% | -36.81% | -11.50% | 0.42% | 48.14 | 41.73 | 4.03 | |
15.38 | 1,463.58 | 14.1 | 23.87 | 15.57 | -1.60% | -6.45% | -29.51% | -28.00% | 94.68% | 0.00% | 23.31 | 41.73 | 3.90 | |
37.31 | 1,668.32 | 5.86 | 44.31 | 38.10 | -6.58% | -9.02% | 187.00% | 499.84% | 4,395.18% | 0.03% | 141.11 | 41.73 | 25.35 | |
428.00 | 1,359.97 | 372.35 | 745 | 430.60 | -0.29% | -10.00% | -19.88% | 8.57% | 1.11% | 0.23% | 26.52 | 41.73 | 2.79 | |
776.15 | 1,658.78 | 665.1 | 1178.85 | 787.00 | -1.67% | -17.91% | -15.08% | -30.94% | 196.30% | 0.73% | 24.77 | 41.73 | 3.11 | |
35.17 | 1,416.51 | 30.51 | 59.59 | 37.07 | 3.29% | -4.20% | -34.37% | -34.73% | 20.86% | 0.27% | 31.15 | 41.73 | 3.03 |
Jagsonpal Pharmaceuticals Share Price FAQs
What is Share Price of Jagsonpal Pharmaceuticals ?
Jagsonpal Pharmaceuticals share price is ₹216.77 in NSE and ₹216.5 in BSE as on 2/12/2025.
How has Jagsonpal Pharmaceuticals shares performed in the past ?
Jagsonpal Pharmaceuticals share price in the past 1-year return was -26.23. The Jagsonpal Pharmaceuticals share hit a 1-year low of Rs. 192.85 and a 1-year high of Rs. 325.7.
What is the market cap of Jagsonpal Pharmaceuticals ?
The market cap of Jagsonpal Pharmaceuticals is Rs. 1453.63 Cr. as of 2/12/2025.
What is the current P/E ratio of Jagsonpal Pharmaceuticals ?
The PE ratios of Jagsonpal Pharmaceuticals is 33.36 as of 2/12/2025.
What is the current PB ratio of Jagsonpal Pharmaceuticals ?
The PB ratios of Jagsonpal Pharmaceuticals is 5.77 as of 2/12/2025
How to buy Jagsonpal Pharmaceuticals shares?
You can easily buy Jagsonpal Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Jagsonpal Pharmaceuticals ?
The 52-week high and low of Jagsonpal Pharmaceuticals share price is ₹325.7 and ₹192.85 as of 2/12/2025.
Please be aware that Jagsonpal Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.
Invest in Jagsonpal Pharmaceuticals